Access cutting-edge non-small cell lung cancer treatment through this clinical trial at a research site in Corona. Study-provided care at no cost to qualified participants.
Access non-small cell lung cancer specialists in Corona at no cost
This study follows strict safety protocols and ethical guidelines
All study-related non-small cell lung cancer treatment provided free
The primary purpose of the study is to assess how well amivantamab in combination with lazertinib or in combination with chemotherapy works (antitumor activity) in participants with epidermal growth factor receptor mutated (EGFRm) non-small cell lung cancer (NSCLC; that is one of the major types of lung cancer).
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this non-small cell lung cancer clinical trial in Corona, CA
If you're searching for non-small cell lung cancer treatment options in Corona, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Corona research site is actively enrolling participants for this clinical trial. You'll receive care from experienced non-small cell lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.